Challenges in developing response evaluation criteria for peptide receptor radionuclide therapy: A consensus report from the European Neuroendocrine Tumor Society Advisory Board Meeting 2022 and the ENETS Theranostics Task Force

Documenti analoghi

• Controversies in NEN: An ENETS position statement on nutritional support in neuroendocrine neoplasms
  di: Simona Grozinsky‐Glasberg, et al.
  Pubblicazione: (2025)
• European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well‐differentiated small intestine neuroendocrine tumours
  di: Angela Lamarca, et al.
  Pubblicazione: (2024)
• Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence ( CoE ): Survey from the ENETS lung NET task force
  di: Anna Koumarianou, et al.
  Pubblicazione: (2024)
• Screening and surveillance practices for Multiple Endocrine Neoplasia type 1‐related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence ( ENETS CoE )—An ENETS MEN1 task force questionnaire study
  di: Carolina R. C. Pieterman, et al.
  Pubblicazione: (2024)
• PRRT in high‐grade digestive neuroendocrine neoplasms ( NET G3 and NEC )
  di: Halfdan Sorbye, et al.
  Pubblicazione: (2024)